Clinical trial
Safety Study About the mRNA Vaccines Against COVID-19 in Pediatric Patients (PEDIVACOV-HCSC)
NCT06646744 is registered in ClinicalTrials.gov with Ana Belen Rivas Paterna as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety Study About the mRNA Vaccines Against COVID-19 in Pediatric Patients (PEDIVACOV-HCSC)
- Lead sponsor
- Ana Belen Rivas Paterna
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 8, 2022
- Completion date
- March 3, 2023
- Enrollment
- 2,100 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
covid-19 vaccine adverse reaction